Medicare Enrolled

Dr. Oksana Demediuk, MD

Ophthalmology · Augusta, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
3520 WALTON WAY EXT, Augusta, GA 30909
7064819191
Registered in NPPES since 2005
NPI: 1972599496 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Demediuk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Demediuk? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Demediuk

Dr. Oksana Demediuk is an ophthalmology specialist in Augusta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Demediuk performed 20,009 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Demediuk received a total of $15,549 from 18 pharmaceutical and/or device companies across 57 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Demediuk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 7% volume in GA $15,549 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
20,009
Medicare services
Top 7% in GA for ophthalmology
Not available
Unique patients (not deduplicated)
$144
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
10,260 $29 $65
Aflibercept eye injection (Eylea) 2,262 $692 $1,498
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,143 $28 $113
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,814 $79 $944
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
788 $217 $1,135
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
586 $83 $169
Injection, ranibizumab, 0.1 mg 467 $180 $497
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
389 $25 $142
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
259 $96 $289
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
216 $77 $248
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
198 $60 $155
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
189 $2,115 $7,858
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
104 $113 $307
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
101 $17 $94
Ranibizumab-nuna biosimilar injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-nuna (Byooviz) at a dose of 0.1 mg.
100 $165 $542
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
62 $31 $335
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
36 $250 $2,417
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
35 $100 $298
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,549
Total received (2018-2024)
Avg $2,221/year across 7 years
Top 11% in GA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
57
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$497
2023
$650
2022
$10,882
2021
$1,217
2020
$766
2019
$1,082
2018
$455

Payments by company (2024)

Genentech USA, Inc.
$208
Regeneron Healthcare Solutions, Inc.
$148
Astellas Pharma US Inc
$53
Sandoz Inc.
$35
Coherus Biosciences Inc.
$30
Bausch & Lomb Americas Inc.
$24
Top 3 companies account for 82.2% of 2024 payments
All-time payments by company (2018-2024) ›
US Retina LLC
$13,840
Regeneron Healthcare Solutions, Inc.
$425
Genentech USA, Inc.
$325
Astellas Pharma US Inc
$178
Dutch Ophthalmic, USA
$131
Alimera Sciences, Inc.
$111
Biogen, Inc.
$107
Kala Pharmaceuticals, Inc.
$106
Coherus Biosciences Inc.
$72
Bausch & Lomb Americas Inc.
$44
Apellis Pharmaceuticals, Inc.
$40
Sandoz Inc.
$35
Mallinckrodt Hospital Products Inc.
$34
Eyevance Pharmaceuticals LLC
$32
Bausch & Lomb, a division of Bausch Health US, LLC
$20
Novartis Pharmaceuticals Corporation
$20
EyePoint Pharmaceuticals US, Inc.
$16
Alcon Vision LLC
$14
Top 3 companies account for 93.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · Cimerli · EVA Ophthalmic Surgical System · EYLEA · EYLEA HD · EYSUVIS · Flarex · ILUVIEN · INVELTYS · Izervay · LOTEMAX · Lucentis · Syfovre · Tobradex ST · VABYSMO · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Augusta?
Compare ophthalmologists in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
44
County median income
$53,197
Nearest hospital to ZIP centroid (approximate)
DOCTORS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Demediuk is a mixed practice specialist, with above-average Medicare volume (top 7% in GA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Demediuk experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Demediuk performed 10,260 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Demediuk receive payments from pharmaceutical companies?
Yes. Dr. Demediuk received a total of $15,549 from 18 companies across 57 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Demediuk's costs compare to other ophthalmologists in Augusta?
Dr. Demediuk's average Medicare payment per service is $144. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Demediuk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →